What is the recommended treatment for a Urinary Tract Infection (UTI) caused by Candida in a patient undergoing Hemodialysis (HD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Candida UTI in Hemodialysis Patients

For urinary tract infections caused by Candida in hemodialysis patients, oral fluconazole at a dose of 200-400 mg daily for 2 weeks is the recommended first-line treatment for fluconazole-susceptible species. 1

Treatment Algorithm Based on Candida Species

Fluconazole-Susceptible Candida (including C. albicans)

  • Oral fluconazole 200-400 mg (3-6 mg/kg) daily for 2 weeks 1
  • Remove indwelling bladder catheter if present 1
  • Eliminate urinary tract obstruction if present 1

Fluconazole-Resistant C. glabrata

  • Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1
  • Alternative: oral flucytosine 25 mg/kg 4 times daily for 7-10 days 1
  • Consider combination therapy with amphotericin B deoxycholate plus flucytosine for severe infections 1

C. krusei Infections

  • Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1
  • Remove indwelling catheter if present 1

Special Considerations for Hemodialysis Patients

  • Fluconazole requires dose adjustment in hemodialysis patients - administer the full dose (200-400 mg) after each dialysis session 2
  • Monitor for drug interactions between antifungals and other medications commonly used in hemodialysis patients 3
  • Amphotericin B formulations should be used with caution due to potential nephrotoxicity, even in patients already on dialysis 1
  • For patients with fungus balls or severe obstruction, consider surgical intervention 1

Management Based on Infection Site

Candida Cystitis

  • Fluconazole 200 mg daily for 2 weeks for susceptible species 1
  • For resistant species, consider amphotericin B bladder irrigation (50 mg/L sterile water daily for 5 days) as adjunctive therapy 1
  • Remove indwelling catheter if present 1

Candida Pyelonephritis

  • Fluconazole 200-400 mg daily for 2 weeks for susceptible species 1
  • For resistant species, amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days with or without flucytosine 1
  • Address any urinary tract obstruction or stents/nephrostomy tubes 1
  • Consider replacement of nephrostomy tubes or stents if present 1

Fungus Ball or Severe Infection

  • Surgical intervention is strongly recommended 1
  • Systemic antifungal therapy as outlined above 1
  • Consider irrigation through nephrostomy tubes with amphotericin B deoxycholate (25-50 mg in 200-500 mL sterile water) if tubes are present 1, 3

Important Caveats

  • Echinocandins (caspofungin, micafungin, anidulafungin) achieve minimal urinary concentrations and are not recommended for Candida UTI 3, 4
  • Newer azoles (voriconazole, posaconazole) also do not achieve adequate urine concentrations 4
  • Asymptomatic candiduria generally does not require treatment unless the patient is at high risk for dissemination 1, 2
  • For patients undergoing urologic procedures, prophylactic fluconazole 400 mg daily or amphotericin B deoxycholate 0.3-0.6 mg/kg daily for several days before and after the procedure is recommended 1
  • Treatment duration should be extended if resolution is delayed or if there are signs of systemic infection 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Candida urinary tract infections in adults.

World journal of urology, 2020

Research

Candida urinary tract infections--treatment.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011

Research

Candida urinary tract infections: treatment options.

Expert review of anti-infective therapy, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.